{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:14:03Z","timestamp":1771643643242,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113745","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:42:40Z","timestamp":1628397760000},"page":"113745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis"],"prefix":"10.1016","volume":"225","author":[{"given":"Ehab","family":"Ghazy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tino","family":"Heimburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Lancelot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Zeyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Schmidtkunz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Truhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-6961","authenticated-orcid":false,"given":"Conrad V.","family":"Simoben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6983-7966","authenticated-orcid":false,"given":"Tajith B.","family":"Shaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-0984","authenticated-orcid":false,"given":"Frank","family":"Erdmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Robaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Romier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9820-8608","authenticated-orcid":false,"given":"Raymond","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5985-9261","authenticated-orcid":false,"given":"Wolfgang","family":"Sippl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113745_bib1","year":"2021","journal-title":"Schistosomiasis"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113745_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.actatropica.2012.04.013","article-title":"Time to set the agenda for schistosomiasis elimination","volume":"128","author":"Rollinson","year":"2013","journal-title":"Acta Trop."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113745_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0035-9203(02)90405-0","article-title":"Resistance of Schistosoma mansoni to praziquantel: is there a problem?","volume":"96","author":"Doenhoff","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113745_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113745_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.4155\/fmc.15.25","article-title":"Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives","volume":"7","author":"Marek","year":"2015","journal-title":"Future Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2021.113745_bib6","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/cmdc.201800572","article-title":"Chemotherapy for fighting schistosomiasis: past, present and future","volume":"13","author":"Mader","year":"2018","journal-title":"ChemMedChem"},{"issue":"317","key":"10.1016\/j.ejmech.2021.113745_bib7","first-page":"317","article-title":"Epigenetic control of gene function in schistosomes: a source of therapeutic targets?","volume":"5","author":"Cabezas-Cruz","year":"2014","journal-title":"Front. Genet."},{"issue":"24","key":"10.1016\/j.ejmech.2021.113745_bib8","first-page":"3567","article-title":"Targeting schistosome histone modifying enzymes for drug development","volume":"18","author":"Pierce","year":"2012","journal-title":"Curr. Pharmaceut. Des."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113745_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pt.2010.09.001","article-title":"Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective?","volume":"27","author":"Dissous","year":"2011","journal-title":"Trends Parasitol."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113745_bib10","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1590\/S0074-02762011000700003","article-title":"Chromatin regulation in schistosomes and histone modifying enzymes as drug targets","volume":"106","author":"Pierce","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.ejmech.2021.113745_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fonc.2018.00092","article-title":"Combination therapy with histone deacetylase inhibitors (HDACi) for the treatment of cancer: achieving the full therapeutic potential of HDACi","volume":"8","author":"Suraweera","year":"2018","journal-title":"Front Oncol"},{"issue":"19\u201320","key":"10.1016\/j.ejmech.2021.113745_bib12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cca.2010.06.020","article-title":"Role of histone acetylation in cell physiology and diseases: an update","volume":"411","author":"Khan","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/cb500846u","article-title":"Metabolic regulation of histone post-translational modifications","volume":"10","author":"Fan","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/icb.2011.97","article-title":"HDAC inhibitors in parasitic diseases","volume":"90","author":"Andrews","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113745_bib15","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1021\/acs.jmedchem.6b01595","article-title":"Lysine deacetylase inhibitors in parasites: past, present, and future perspectives","volume":"60","author":"Hailu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113745_bib16","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/j.ejmech.2010.02.030","article-title":"Inside HDAC with HDAC inhibitors","volume":"45","author":"Bertrand","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib17","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113745_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.meegid.2017.05.011","article-title":"Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseases","volume":"53","author":"Scholte","year":"2017","journal-title":"Infect. Genet. Evol."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113745_bib19","doi-asserted-by":"crossref","first-page":"e2428","DOI":"10.1371\/journal.pntd.0002428","article-title":"Schistosoma mansoni Sirtuins: characterization and potential as chemotherapeutic targets","volume":"7","author":"Lancelot","year":"2013","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"19","key":"10.1016\/j.ejmech.2021.113745_bib20","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1021\/acs.jmedchem.9b00638","article-title":"Structure-reactivity relationships on substrates and inhibitors of the lysine deacylase sirtuin 2 from schistosoma mansoni (SmSirt2)","volume":"62","author":"Monaldi","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2021.113745_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4155\/fmc.15.24","article-title":"Schistosome sirtuins as drug targets","volume":"7","author":"Lancelot","year":"2015","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molbiopara.2009.06.001","article-title":"Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni","volume":"168","author":"Dubois","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113745_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.exppara.2008.11.010","article-title":"Schistosoma mansoni: developmental arrest of miracidia treated with histone deacetylase inhibitors","volume":"121","author":"Azzi","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113745_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.bbrc.2008.10.090","article-title":"The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni","volume":"377","author":"Oger","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113745_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201700096","article-title":"Isophthalic acid-based HDAC inhibitors as potent inhibitors of HDAC8 from schistosoma mansoni","volume":"350","author":"Stenzel","year":"2017","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s13071-018-3268-8","article-title":"Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production","volume":"11","author":"Guidi","year":"2018","journal-title":"Parasites Vectors"},{"issue":"7","key":"10.1016\/j.ejmech.2021.113745_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/cmdc.201900583","article-title":"Structure-based design, synthesis, and biological evaluation of triazole-based smHDAC8 inhibitors","volume":"15","author":"Kalinin","year":"2020","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1021\/acsinfecdis.9b00224","article-title":"Screening and phenotypical characterization of schistosoma mansoni histone deacetylase 8 (SmHDAC8) inhibitors as multistage antischistosomal agents","volume":"6","author":"Saccoccia","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113745_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cbpa.2020.05.008","article-title":"Targeting histone acetylation\/deacetylation in parasites: an update (2017-2020)","volume":"57","author":"Fioravanti","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2021.113745_bib30","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1021\/ci5004653","article-title":"Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in\u00a0vitro validation","volume":"54","author":"Kannan","year":"2014","journal-title":"J.\u00a0Chem. Inf. Model."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113745_bib31","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/molecules23030566","article-title":"A\u00a0novel class of schistosoma mansoni histone deacetylase 8 (HDAC8) inhibitors identified by structure-based virtual screening and in\u00a0vitro testing","volume":"23","author":"Simoben","year":"2018","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.ejmech.2021.113745_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003645","article-title":"Structural basis for the inhibition of histone deacetylase 8 (HDAC8), a key epigenetic player in the blood fluke Schistosoma mansoni","volume":"9","author":"Marek","year":"2013","journal-title":"PLoS Pathog."},{"issue":"15","key":"10.1016\/j.ejmech.2021.113745_bib33","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1002\/cmdc.201800238","article-title":"Synthesis, crystallization studies, and in\u00a0vitro characterization of cinnamic acid derivatives as SmHDAC8 inhibitors for the treatment of schistosomiasis","volume":"13","author":"Bayer","year":"2018","journal-title":"ChemMedChem"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113745_bib34","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.jmedchem.5b01478","article-title":"Structure-based design and synthesis of novel inhibitors targeting HDAC8 from schistosoma mansoni for the treatment of schistosomiasis","volume":"59","author":"Heimburg","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2021.113745_bib35","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1021\/acs.jmedchem.8b01087","article-title":"Characterization of histone deacetylase 8 (HDAC8) selective inhibition reveals specific active site structural and functional determinants","volume":"61","author":"Marek","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"issue":"24","key":"10.1016\/j.ejmech.2021.113745_bib36","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1021\/acs.jmedchem.7b01447","article-title":"Structure-based design and biological characterization of selective histone deacetylase 8 (HDAC8) inhibitors with anti-neuroblastoma activity","volume":"60","author":"Heimburg","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113745_bib37","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/molecules26092584","article-title":"Binding free energy (BFE) calculations and quantitative structure\u2013activity relationship (QSAR) analysis of schistosoma mansoni histone deacetylase 8 (smHDAC8) inhibitors","volume":"26","author":"Simoben","year":"2021","journal-title":"Molecules"},{"issue":"22","key":"10.1016\/j.ejmech.2021.113745_bib38","doi-asserted-by":"crossref","first-page":"9562","DOI":"10.1021\/jm300837y","article-title":"Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate libraries","volume":"55","author":"Suzuki","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113745_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009226","article-title":"The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs","volume":"15","author":"Vaca","year":"2021","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2021.113745_bib40","doi-asserted-by":"crossref","first-page":"112338","DOI":"10.1016\/j.ejmech.2020.112338","article-title":"Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6\/8 and bromodomain BRPF1","volume":"200","author":"Ghazy","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113745_bib41","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/cmdc.201200193","article-title":"Design, synthesis, and biological evaluation of 2-aminobenzanilide derivatives as potent and selective HDAC inhibitors","volume":"7","author":"Stolfa","year":"2012","journal-title":"ChemMedChem"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113745_bib42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/0014-4894(74)90076-9","article-title":"Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in\u00a0vitro","volume":"36","author":"Ramalho-Pinto","year":"1974","journal-title":"Exp. Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113745_bib43","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"7","key":"10.1016\/j.ejmech.2021.113745_bib44","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421005948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:30:02Z","timestamp":1759329002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421005948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S0223523421005948"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113745","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113745"}}